News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
227 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17894)
Month
January (3339)
February (3294)
March (4068)
April (3458)
May (4782)
June (3455)
July (2690)
August (3589)
September (3334)
October (3977)
November (4082)
December (2500)
Day
1 (66)
3 (2)
4 (14)
5 (297)
6 (263)
7 (227)
8 (79)
9 (6)
10 (9)
11 (173)
12 (214)
13 (136)
14 (156)
15 (56)
17 (3)
18 (145)
19 (230)
20 (173)
21 (177)
22 (79)
23 (2)
25 (134)
26 (227)
27 (192)
28 (175)
29 (97)
30 (2)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
3
4
5
6
7
8
9
10
11
12
13
14
15
17
18
19
20
21
22
23
25
26
27
28
29
30
Lone Star Bio
Coya Therapeutics Successfully Engineers Regulatory T Cell (Treg) Derived Exosomes with CTLA-4 Protein to Selectively Target Immune Cells with Potential to Deliver Targeted Therapies Across Multiple Diseases
Coya Therapeutics, Inc. announced that Dr. Phil Campbell, Professor of Biomedical Engineering at CMU, presented his talk, “Rapid Functionalization of Treg Exosomes for Targeted Immunotherapy” at the 5th Exosome Based Therapeutic Development Summit in Boston, MA this morning (September 7, 2023).
September 7, 2023
·
8 min read
Lone Star Bio
Natera Announces Pricing of $250 Million Follow-On Offering
Natera, Inc., a global leader in cell-free DNA testing, announced the pricing of its underwritten public offering of 4,550,000 shares of its common stock at a price to the public of $55.00 per share.
September 7, 2023
·
3 min read
Drug Development
Valneva and Pfizer Report Positive Pediatric and Adolescent Phase 2 Booster Results for Lyme Disease Vaccine Candidate
Valneva SE and Pfizer Inc. announced positive pediatric and adolescent immunogenicity and safety data for their Lyme disease vaccine candidate, VLA15, when given as a booster.
September 7, 2023
·
14 min read
Policy
MaaT Pharma Announces European Medicines Agency Granted MaaT033 Orphan Drug Designation aiming to improve overall survival in patients undergoing Hematopoietic Stem Cell transplantation
MaaT Pharma announced that the European Medicines Agency has granted MaaT033 orphan drug designation aiming to improve overall survival in patients undergoing HSCT and has recognized the significant benefit that MaaT033 could therefore bring to this patient’s population.
September 7, 2023
·
4 min read
Business
Angle PLC Announces Interim Results for the Period Ended 30 June 2023
ANGLE plc, a world-leading liquid biopsy company with innovative circulating tumor cell diagnostic solutions for the research and diagnostic oncology market, announces its unaudited interim financial results for the six months ended 30 June 2023.
September 7, 2023
·
6 min read
Drug Development
Actimed Therapeutics announces FDA approval of its Investigational New Drug application for Phase 2b/3 IMPACT clinical trials of S-pindolol benzoate to treat cancer cachexia
Actimed Therapeutics Ltd announces that it has received approval from the US FDA for its IND application for one Phase 2b/3 clinical study of S-pindolol benzoate to treat cachexia associated with colorectal cancer and another in patients with non-small cell lung cancer.
September 7, 2023
·
5 min read
Deals
Life Science: Cerba HealthCare to Acquire Canadian Contract Research Laboratory CIRION BioPharma Research to Expand Bioanalytical Capabilities and Shorten Time-to-Deploy Complex Clinical Trials
Cerba HealthCare, a leading global player in medical diagnosis, announced it has acquired CIRION BIOPHARMA RESEARCH INC, a Canadian-controlled private company highly recognized for its integrated bioanalytical and global central laboratory services.
September 7, 2023
·
6 min read
Biotech Bay
Adagene to Present at Investor and Scientific Conferences in September 2023
Adagene Inc., a platform-driven, clinical-stage biotechnology company transforming the discovery and development of novel antibody-based therapies, announced the company’s participation in several upcoming investor and scientific conferences.
September 7, 2023
·
2 min read
Drug Development
Phanes Therapeutics Announces First Patient Dosed in Phase 1 Study of PT217 for Small Cell Lung Cancer and Other Neuroendocrine Cancers Expressing DLL3
Phanes Therapeutics, Inc. announced that the first patient has been dosed in the Phase 1 clinical study of PT217, a first-in-class native IgG-like bispecific antibody targeting DLL3 and CD47 for the treatment of small cell lung cancer and other neuroendocrine tumors.
September 7, 2023
·
2 min read
Biotech Bay
Adiso Therapeutics to Participate in Upcoming September 2023 Investor Conferences
Adiso Therapeutics, Inc. announced that Scott Megaffin, Chief Executive Officer, and members of the Adiso Corporate Staff will participate in the following upcoming investor conferences.
September 7, 2023
·
2 min read
Previous
14 of 23
Next